PMEL and neoplasm: With regard to tumor Ag vaccines, in a trial with MART-1, gp100 and tyrosinase peptides in metastatic CM patients, one of the patients who experienced a dramatic tumor regression had preexisting immunity to TRP2 and NY-ESO-1 Ag [76].